SEC Form D filing

Mitera Biosciences Inc., 2026-05-06

An SEC Form D private-offering notice from Bellevue, WA, a $3,000,000 filer-stated offering target in Biotech. Filed 2026-05-06. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Mitera Biosciences Inc. site↗ Verified via SEC Form D

Develops immune tolerance based therapeutics for autoimmune disease and organ transplant rejection, inspired by placental immune biology

Filed 2026-05-06Filed to raise $3,000,000First money in 2026-04-21Raised so far $1,100,000HQ (as filed) Bellevue, WASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified miterabio.com↗Named in the filing 1 executive & director
Open this row on the live feed →More new filings in Washington →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source